Please download the dossier by clicking on the dossier button x
×

Modified Release Formulations Of A Bupropion Salt

  • US 20150202147A1
  • Filed: 09/02/2014
  • Published: 07/23/2015
  • Est. Priority Date: 06/27/2005
  • Status: Active Grant
First Claim
Patent Images

1. A modified release osmotic dosage form comprising bupropion hydrobromide present in a therapeutically effective amount, wherein said dosage form releases the bupropion hydrobromide by dispensing the bupropion hydrobromide from a core via at least one passageway in a membrane by pressure created in the core by osmosis and/or by the expansion of a swellable material which forces the bupropion hydrobromide to be dispensed from the core of the dosage form.

View all claims
  • 15 Assignments
Timeline View
Assignment View
    ×
    ×